- Medisafe, a Boston, MA-based digital therapeutics company creating digital drug companions, raised $30m in Series C funding
- The round led by Sanofi Ventures and Alive Israel HealthTech Fund, also joined by Leumi Partners, Menorah Mivtachim and Consensus Business Group
- In conjunction with the funding, Cris De Luca, Global Head, Digital Investments at Sanofi Ventures and David Klein, Co-Founder, Managing Partner ALIVE Israel HealthTech Fund will join Medisafe’s board of directors
- The company intends to use the funds to further expand its end-to-end solutions supporting patients managing medications and accelerate revenues growth
- Founded in 2012 and led by Omri Shor, CEO, Medisafe isa medication management platform with over 7M registered users globally
- Over the past eight years, Medisafe has amassed a database of over four billion dosage behaviors informing JITI to maximize engagement and driving outcomes
